Searches , social queries for ALOGLIPTIN

Search references for ALOGLIPTIN. Phrases containing ALOGLIPTIN

See searches and references containing ALOGLIPTIN!

Searches containing ALOGLIPTIN

ALOGLIPTIN

  • Alogliptin

    • Anti-diabetic drug

    Alogliptin, sold under the brand names Nesina and Vipidia, is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class. Like other members of

    Alogliptin

    Alogliptin

    Alogliptin

  • Dipeptidyl peptidase-4 inhibitor

    • Enzyme blocker and diabetes treatment drug

    Kowa Company, Ltd.) Teneligliptin (approved in Japan as Tenelia in 2012) Alogliptin (FDA approved in 2013 as Nesina/Vipidia, and marketed by Takeda Pharmaceutical

    Dipeptidyl peptidase-4 inhibitor

    Dipeptidyl peptidase-4 inhibitor

    Dipeptidyl_peptidase-4_inhibitor

  • Glucagon-like peptide-1

    • Gastrointestinal peptide hormone involved in glucose homeostasis

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Glucagon-like peptide-1

    Glucagon-like peptide-1

    Glucagon-like_peptide-1

  • Orforglipron

    • Anti-obesity medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Orforglipron

    Orforglipron

    Orforglipron

  • Brenipatide

    • Pharmaceutical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Brenipatide

    Brenipatide

  • Metformin

    • Medication used to treat diabetes

    saxagliptin/metformin combination (Kombiglyze XR, Komboglyze), and an alogliptin/metformin combination (Kazano, Vipdomet). Linagliptin combined with metformin

    Metformin

    Metformin

    Metformin

  • Sitagliptin

    • Diabetes medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Sitagliptin

    Sitagliptin

    Sitagliptin

  • Diabetes medication

    • Drugs that lower blood glucose levels to treat diabetes

    FDA Approved July 2009 linagliptin (Tradjenta) FDA Approved May 2, 2011 alogliptin septagliptin teneligliptin gemigliptin (Zemiglo) DPP-4 inhibitors lowered

    Diabetes medication

    Diabetes_medication

  • Semaglutide

    • Anti-diabetic and anti-obesity medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Semaglutide

    Semaglutide

    Semaglutide

  • Empagliflozin

    • Diabetes medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Empagliflozin

    Empagliflozin

  • Insulin efsitora alfa

    • Medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin efsitora alfa

    Insulin_efsitora_alfa

  • Insulin degludec

    • Ultralong-acting basal insulin analogue

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin degludec

    Insulin degludec

    Insulin_degludec

  • Lotiglipron

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Lotiglipron

    Lotiglipron

    Lotiglipron

  • Trelagliptin

    • Chemical compound

    antigens (specifically CD26). Chemically, it is a fluorinated derivative of alogliptin. Formulated as the salt trelagliptin succinate, it was approved for use

    Trelagliptin

    Trelagliptin

    Trelagliptin

  • Dulaglutide

    • Diabetes medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Dulaglutide

    Dulaglutide

    Dulaglutide

  • Retatrutide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Retatrutide

    Retatrutide

    Retatrutide

  • Nathaniel David

    • American scientist and entrepreneur

    contributed to the development of multiple FDA-approved medicines, including alogliptin, trelagliptin, gemigliptin, plazomicin, and deoxycholic acid. David earned

    Nathaniel David

    Nathaniel David

    Nathaniel_David

  • Alpha-glucosidase inhibitor

    • Oral anti-diabetic drugs

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Alpha-glucosidase inhibitor

    Alpha-glucosidase_inhibitor

  • Insulin tregopil

    • Pharmaceutical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin tregopil

    Insulin_tregopil

  • Insulin analogue

    • Modified forms of synthetic insulin

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin analogue

    Insulin analogue

    Insulin_analogue

  • ATC code A10

    • Pharmaceutical drug classification

    alogliptin A10BD10 Metformin and saxagliptin A10BD11 Metformin and linagliptin A10BD12 Pioglitazone and sitagliptin A10BD13 Metformin and alogliptin A10BD14

    ATC code A10

    ATC_code_A10

  • NPH insulin

    • Intermediate acting insulin formulation

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    NPH insulin

    NPH insulin

    NPH_insulin

  • GLP1 poly-agonist peptides

    • Class of drugs used to treat diabetes

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    GLP1 poly-agonist peptides

    GLP1_poly-agonist_peptides

  • Insulin icodec

    • Ultralong-acting basal insulin analogue

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin icodec

    Insulin_icodec

  • Empagliflozin/linagliptin/metformin

    • Combination drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Empagliflozin/linagliptin/metformin

    Empagliflozin/linagliptin/metformin

  • Insulin glargine

    • Long-acting insulin

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin glargine

    Insulin glargine

    Insulin_glargine

  • Tirzepatide

    • Anti-diabetic and anti-obesity medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Tirzepatide

    Tirzepatide

    Tirzepatide

  • Saxagliptin

    • Chemical compound

    Human Medical Products - Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure". www.fda.gov. Retrieved

    Saxagliptin

    Saxagliptin

    Saxagliptin

  • Dapagliflozin

    • Diabetes medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Dapagliflozin

    Dapagliflozin

    Dapagliflozin

  • Biguanide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Biguanide

    Biguanide

    Biguanide

  • Glibenclamide/metformin

    • Combination drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Glibenclamide/metformin

    Glibenclamide/metformin

  • Sulfonylurea

    • Class of organic compounds used in medicine and agriculture

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Sulfonylurea

    Sulfonylurea

    Sulfonylurea

  • Canagliflozin/metformin

    • Fixed-dose combination anti-diabetic medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Canagliflozin/metformin

    Canagliflozin/metformin

  • RX871024

    • Experimental anti-diabetic drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    RX871024

    RX871024

    RX871024

  • Linagliptin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Linagliptin

    Linagliptin

    Linagliptin

  • Insulin icodec/semaglutide

    • Combination drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin icodec/semaglutide

    Insulin_icodec/semaglutide

  • Insulin glulisine

    • Rapid-acting insulin analogue

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin glulisine

    Insulin glulisine

    Insulin_glulisine

  • Insulin aspart

    • Rapid-acting man-made insulin

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin aspart

    Insulin aspart

    Insulin_aspart

  • Buformin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Buformin

    Buformin

    Buformin

  • Muraglitazar

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Muraglitazar

    Muraglitazar

    Muraglitazar

  • SGLT2 inhibitor

    • Class of medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    SGLT2 inhibitor

    SGLT2_inhibitor

  • Vildagliptin/metformin

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Vildagliptin/metformin

    Vildagliptin/metformin

  • Insulin (medication)

    • Use of insulin protein and analogs as medical treatment

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin (medication)

    Insulin (medication)

    Insulin_(medication)

  • Donislecel

    • Cellular therapy medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Donislecel

    Donislecel

  • Pioglitazone

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Pioglitazone

    Pioglitazone

    Pioglitazone

  • Sorbinil

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Sorbinil

    Sorbinil

    Sorbinil

  • Liraglutide

    • Anti-diabetic medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Liraglutide

    Liraglutide

    Liraglutide

  • Meglitinide

    • Chemical substance

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Meglitinide

    Meglitinide

    Meglitinide

  • Insulin glargine/lixisenatide

    • Combination drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin glargine/lixisenatide

    Insulin_glargine/lixisenatide

  • Sotagliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Sotagliflozin

    Sotagliflozin

  • Sitagliptin/metformin

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Sitagliptin/metformin

    Sitagliptin/metformin

  • Canagliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Canagliflozin

    Canagliflozin

    Canagliflozin

  • Tofogliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Tofogliflozin

    Tofogliflozin

    Tofogliflozin

  • Velagliflozin

    • Medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Velagliflozin

    Velagliflozin

    Velagliflozin

  • Exenatide

    • Medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Exenatide

    Exenatide

    Exenatide

  • PPAR agonist

    • Drug used for the treatment of symptoms of metabolic syndrome

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    PPAR agonist

    PPAR agonist

    PPAR_agonist

  • Conveglipron

    • Pharmaceutical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Conveglipron

    Conveglipron

    Conveglipron

  • Fotagliptin

    • Chemical compound

    produced GLP-1 and GIP. In a phase 3 trial it showed similar results as alogliptin. Wu, Min; Li, Qian-Qian; Zhang, Hong; Zhu, Xiao-Xue; Li, Xiao-Jiao; Li

    Fotagliptin

    Fotagliptin

    Fotagliptin

  • Saroglitazar

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Saroglitazar

    Saroglitazar

    Saroglitazar

  • Enavogliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Enavogliflozin

    Enavogliflozin

    Enavogliflozin

  • Dapagliflozin/sitagliptin

    • Medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Dapagliflozin/sitagliptin

    Dapagliflozin/sitagliptin

  • Lente insulin

    • Historical formulation of insulin as medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Lente insulin

    Lente insulin

    Lente_insulin

  • Taspoglutide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Taspoglutide

    Taspoglutide

  • Vildagliptin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Vildagliptin

    Vildagliptin

    Vildagliptin

  • Teneligliptin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Teneligliptin

    Teneligliptin

    Teneligliptin

  • Englitazone

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Englitazone

    Englitazone

    Englitazone

  • Anagliptin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Anagliptin

    Anagliptin

    Anagliptin

  • Insulin degludec/liraglutide

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin degludec/liraglutide

    Insulin_degludec/liraglutide

  • Gliclazide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Gliclazide

    Gliclazide

    Gliclazide

  • Empagliflozin/linagliptin

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Empagliflozin/linagliptin

    Empagliflozin/linagliptin

    Empagliflozin/linagliptin

  • Thiazolidinedione

    • Class of chemical compounds

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Thiazolidinedione

    Thiazolidinedione

    Thiazolidinedione

  • Dasiglucagon

    • Medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Dasiglucagon

    Dasiglucagon

  • Danuglipron

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Danuglipron

    Danuglipron

    Danuglipron

  • Bexagliflozin

    • Antidiabetic medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Bexagliflozin

    Bexagliflozin

  • Voglibose

    • Alpha-glucosidase inhibitor

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Voglibose

    Voglibose

    Voglibose

  • Albiglutide

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Albiglutide

    Albiglutide

    Albiglutide

  • Fidarestat

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Fidarestat

    Fidarestat

    Fidarestat

  • List of commercially available insulins

    • Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    List of commercially available insulins

    List of commercially available insulins

    List_of_commercially_available_insulins

  • Repaglinide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Repaglinide

    Repaglinide

    Repaglinide

  • Tolrestat

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Tolrestat

    Tolrestat

    Tolrestat

  • Ipragliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Ipragliflozin

    Ipragliflozin

    Ipragliflozin

  • Imeglimin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Imeglimin

    Imeglimin

    Imeglimin

  • Dapagliflozin/metformin

    • Two drugs combined to treat diabetes

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Dapagliflozin/metformin

    Dapagliflozin/metformin

  • Rosiglitazone

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Rosiglitazone

    Rosiglitazone

    Rosiglitazone

  • Empagliflozin/metformin

    • Pharmaceutical drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Empagliflozin/metformin

    Empagliflozin/metformin

  • Regular insulin

    • Short-acting insulin formulation

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Regular insulin

    Regular insulin

    Regular_insulin

  • Insulin lispro

    • Rapid-acting insuline analog

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin lispro

    Insulin lispro

    Insulin_lispro

  • Survodutide

    • Peptide drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Survodutide

    Survodutide

    Survodutide

  • Luseogliflozin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Luseogliflozin

    Luseogliflozin

  • Miglitol

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Miglitol

    Miglitol

    Miglitol

  • Remogliflozin etabonate

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Remogliflozin etabonate

    Remogliflozin etabonate

    Remogliflozin_etabonate

  • Inhalable insulin

    • Powdered insulin delivered with an inhaler

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Inhalable insulin

    Inhalable insulin

    Inhalable_insulin

  • Glipizide

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Glipizide

    Glipizide

    Glipizide

  • Mazdutide

    • GLP1 poly-agonist drug

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Mazdutide

    Mazdutide

  • Insulin detemir

    • Long-acting man-made insulin

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin detemir

    Insulin_detemir

  • Evogliptin

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Evogliptin

    Evogliptin

    Evogliptin

  • Discovery and development of dipeptidyl peptidase-4 inhibitors

    • Drug discovery and development

    any loss of DPP-4 inhibition. Alogliptin was discovered when quinazolinone was replaced with a pyrimidinedione. Alogliptin has shown excellent inhibition

    Discovery and development of dipeptidyl peptidase-4 inhibitors

    Discovery_and_development_of_dipeptidyl_peptidase-4_inhibitors

  • Omarigliptin

    • Chemical compound

    Type 2 Diabetes". Merck Sharp & Dohme Corp. April 8, 2016. Dipeptidyl peptidase-4 inhibitor Alogliptin Linagliptin Saxagliptin Sitagliptin Vildagliptin

    Omarigliptin

    Omarigliptin

    Omarigliptin

  • Aleglitazar

    • Chemical compound

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Aleglitazar

    Aleglitazar

    Aleglitazar

  • Insulin degludec/insulin aspart

    • Combination medication

    Survodutide† (GLP-1/GCGR) Tirzepatide (GLP-1/GIP) DPP-4 inhibitors ("-gliptins") Alogliptin Anagliptin Evogliptin Garvagliptin Gemigliptin Gosogliptin Linagliptin

    Insulin degludec/insulin aspart

    Insulin_degludec/insulin_aspart

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance

Searches for online references containing ALOGLIPTIN

ALOGLIPTIN

Search references containing ALOGLIPTIN

ALOGLIPTIN

Search queries for Facebook and twitter posts, hashtags with ALOGLIPTIN

ALOGLIPTIN

Follow users with usernames @ALOGLIPTIN or posting hashtags containing #ALOGLIPTIN

ALOGLIPTIN

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with ALOGLIPTIN

ALOGLIPTIN

Top search, Social media, medium, facebook & news articles containing ALOGLIPTIN

ALOGLIPTIN

Searches for Acronyms & meanings containing ALOGLIPTIN

ALOGLIPTIN

Searches, Indeed job searches and job offers containing ALOGLIPTIN

Other words and meanings similar to

ALOGLIPTIN

Search in online dictionary sources & meanings containing ALOGLIPTIN

ALOGLIPTIN

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance